Monday September 23, 2019
Home Lead Story Shortage Of B...

Shortage Of Blood Pressure Drugs After Recall: FDA

The agency said that it determined that the impurities "may be generated when specific chemicals and reaction conditions are present in the manufacturing process"

0
//
Blood Pressure, Drugs
A man has his blood pressure checked at a clinic in Wise, Virginia, July 22, 2017. VOA

Additional shortages of blood pressure drugs in the United States are possible following recent recalls related to traces of a probable carcinogen found in some versions a particular class of hypertension medicines, the U.S. Food and Drug Administration said Friday.

The drugs, including valsartan, belong to a class of widely-used medicines for treating high blood pressure called angiotensin II receptor blockers, or ARBs. Valsartan is the generic of Novartis’ Diovan.

The FDA also said it may have identified the root cause of the potentially cancer-causing impurities but that it is still investigating.

The recalls began last summer after the FDA was informed that ingredients used by Chinese manufacturer Zhejiang Huahai Pharmaceuticals Co (Huahai) to produce valsartan contained the impurities. The FDA later halted all imports from one of Huahai’s factories.

Drugs
Some generic versions of other ARBS, such as losartan and irbesartan, have also been recalled.

Other manufacturers have also had to recall valsartan after the impurities were found in their versions of the drug.

It is currently listed as in shortage by the FDA.

Generic drugs

Some generic versions of other ARBS, such as losartan and irbesartan, have also been recalled. The most recent recall was announced earlier this week.

Also Read: New Wearable Patch That Helps in Monitoring Blood Pressure

The agency said that it determined that the impurities “may be generated when specific chemicals and reaction conditions are present in the manufacturing process” and “may also result from the reuse of materials, such as solvents.”

The reuse of solvents is an accepted practice in the industry, but manufacturers are generally expected to ensure that reused materials meet certain safety standards. (VOA)

Next Story

List of Best Penny Marijuana Stocks

As interesting and profitable as marijuana stocks are, they are still mostly penny stocks, the fact that making money off of this little green plant is still considered illegal in countries

0
marijuana, cannabis, penny stocks, stocks, USA, investment
Marijuana grows at an indoor cannabis farm in Gardena, California, Aug. 15, 2019. VOA

As interesting and profitable as marijuana stocks are, they are still mostly penny stocks. This probably has something to do with the fact that making money off of this little green plant is still considered illegal in countries like the United States.

We know some states are changing their laws, but nothing has changed federally just yet. This means investors have to deal with cash most of the time, and sometimes, they can’t take advantage of certain tax deductions. The money made from this industry cannot always be used to open a bank account.

As you can see, there are many obstacles to overcome in this industry.

Some of these factors make it even more important for potential investors to pay attention to the penny stocks they do take a chance on. The following is a list of some of the best penny stocks available today.

1. InMed Pharmaceuticals Inc

When it comes to drug development and commercialization, there are only a few companies that can be compared to this company.

InMed Pharmaceuticals Inc. focuses on Cannabinoids, and they have invested a lot of time and effort into developing the therapeutic aspects of marijuana.

One thing the company is pretty proud of is the bioinformatics assessment tool. This tool allows technicians to figure out if a specific cannabinoid could address certain ailments.

The possibilities with this kind of targeted treatment are endless, which is attracting a number of investors around the globe.

marijuana, penny stocks, stocks, USA, investment
There is also the Aleafia Health stock that focuses on growing
and promoting medical cannabis clinics all around the US. Pixabay

At the moment, it seems like the company has made significant progress towards dealing with Epidermolysis bullosa, glaucoma, and it has also been working hard to address joint and muscle pains.

2. American Cannabis Company Inc.

The American Cannabis Company Inc. is considered the go-to company for entrepreneurs in the United States who are attempting to get into the business of selling marijuana.

Everyone knows that the business is setting itself up for a major boom in the coming years, even though it is already quite profitable.

This company understands that entrepreneurs don't always understand everything there is to know about cannabis, such as marketing it and navigating the current environment surrounding marijuana sales.

The American Cannabis Company Inc. is here to provide counsel, thanks to years of experience in the industry. It is here to provide marketing tools, branding information, and even help with staffing if needed.

Those interested in one of the best penny marijuana stocks out there should definitely pay close attention to this stock.

3. Auxly Cannabis Group

The Auxly Cannabis Group is an important company to watch out for. It is considered a cannabis royalty company, and the reason investors should keep an eye on it is because it is focused on helping growers start or expand their capacity.

If the marijuana industry is set to explode as more countries accept its usage, then there is going to be a need for growers who can provide.

Of course, the company does not only help other growers; it has also purchased its own farms as well.

marijuana, penny stocks, stocks, USA, investment
As interesting and profitable as marijuana stocks are, they are still mostly penny stocks. Pixabay

Projections say that these farms may end up producing up to 170,000 kilograms of marijuana in 2019 and the following year. Those kind of numbers have instilled the kind of faith any company wants to instill in possible investors.

4. Plus Products Inc.

Edibles are going to be an important part of the marijuana industry. These little things are fun, and people are loving them. At the moment, Plus Products Inc. is considered one of the fastest growing edible companies.

It continues to produce the kind of edibles that people want, hitting great numbers. Some of their best-selling edibles have seen great staying power and fend off competition.

It is safe to say that this company is putting a lot of work into the products they produce to make sure customers are happy.

It is currently selling its edibles in California, and that means the rest of the country is ripe for the picking, which means the potential for growth is undeniable.

ALSO READ: Daily Cannabis Use May Increase Risk of Psychosis

Plus Products Inc. is actually developing an even bigger facility that is going to be able to handle even more orders. It is safe to say that the company is foreseeing a huge spike in demand within the coming months or few short years. Investors interested in the the long game should definitely give this stock a try.

Of course, these are just some of the stocks that investors should keep an eye on, but there are more, such as MariMed Inc. that is more of an all-in-one consulting firm helping dispensaries and other players in the industry. There is also the Aleafia Health stock that focuses on growing and promoting medical cannabis clinics all around the US.

As mentioned earlier, the key here is to make sure each investor pays attention to each stock and what the company is attempting to do. We think one should only invest in a stock when the investor feels he or she can make an informed decision.